SEC Form 4 · accession 0000930413-18-000049
ENZO BIOCHEM INC · ENZ
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Dov Perlysky
Director
Period of report
Jan 5, 2018
Accepted (ET)
Jan 9, 2018 · 3:46 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000316253
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (to acquire common stock)F1 | $8.36 | Jan 5, 2018 | A | 36,860 | A | Jan 6, 2019 | Jan 4, 2023 | Common Stock | 36,860 | 276,492 | D |
Explanation of responses
- F1The Reporting Person was granted 36,860 stock options. The options have a five-year term and shall vest in two equal annual tranches, beginning January 06, 2019.